Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction

Abstract

Continuous 48-h treatment with C1-inhibitor provides safe and effective inhibition of complement activation after reperfused acute myocardial infarction and may reduce myocardial injury.